18-66509149-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_021153.4(CDH19):c.1674G>A(p.Pro558=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00613 in 1,612,846 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0054 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0062 ( 44 hom. )
Consequence
CDH19
NM_021153.4 synonymous
NM_021153.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.277
Genes affected
CDH19 (HGNC:1758): (cadherin 19) This gene is one of three related type II cadherin genes situated in a cluster on chromosome 18. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein containing five extracellular cadherin repeats. Loss of cadherins may be associated with cancer formation. Alternative splicing results in multiple transcript variants for this gene. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 18-66509149-C-T is Benign according to our data. Variant chr18-66509149-C-T is described in ClinVar as [Benign]. Clinvar id is 770649.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.277 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH19 | NM_021153.4 | c.1674G>A | p.Pro558= | synonymous_variant | 11/12 | ENST00000262150.7 | NP_066976.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH19 | ENST00000262150.7 | c.1674G>A | p.Pro558= | synonymous_variant | 11/12 | 1 | NM_021153.4 | ENSP00000262150 | P1 | |
CDH19 | ENST00000579658.5 | c.*20G>A | 3_prime_UTR_variant, NMD_transcript_variant | 11/12 | 1 | ENSP00000463085 | ||||
CDH19 | ENST00000540086.5 | c.1459-3847G>A | intron_variant | 2 | ENSP00000439593 |
Frequencies
GnomAD3 genomes AF: 0.00539 AC: 819AN: 151838Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
819
AN:
151838
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00545 AC: 1369AN: 251050Hom.: 10 AF XY: 0.00511 AC XY: 693AN XY: 135688
GnomAD3 exomes
AF:
AC:
1369
AN:
251050
Hom.:
AF XY:
AC XY:
693
AN XY:
135688
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00621 AC: 9067AN: 1460890Hom.: 44 Cov.: 32 AF XY: 0.00592 AC XY: 4300AN XY: 726760
GnomAD4 exome
AF:
AC:
9067
AN:
1460890
Hom.:
Cov.:
32
AF XY:
AC XY:
4300
AN XY:
726760
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00539 AC: 819AN: 151956Hom.: 6 Cov.: 32 AF XY: 0.00572 AC XY: 425AN XY: 74282
GnomAD4 genome
AF:
AC:
819
AN:
151956
Hom.:
Cov.:
32
AF XY:
AC XY:
425
AN XY:
74282
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
CDH19-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 28, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at